[144] Hamilton Insurance Group, Ltd. SEC Filing

Rhea-AI Filing Summary

Hamilton Insurance Group, Ltd. notice reports a proposed sale of 100,000 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $2,331,000 and an approximate sale date of 08/12/2025. The issuer has 65,606,760 shares outstanding. The 100,000 shares were acquired as restricted stock vesting under a registered plan on multiple dates in 2024–2025, with the individual vesting lots listed in the notice and totaling 100,000 shares. Separately, Megan Jane Graves sold 25,000 shares on 05/16/2025 for gross proceeds of $525,500. The filer represents there is no undisclosed material adverse information.

Positive

• Securities were acquired via restricted stock vesting under a registered plan, as disclosed in the filing
• Brokered sale through Morgan Stanley Smith Barney LLC indicates an orderly market channel for the proposed disposition

Negative

• Insider proposes to sell 100,000 shares with an aggregate market value of $2,331,000
• Recent disposition shown: Megan Jane Graves sold 25,000 shares on 05/16/2025 for $525,500

Insights

Securities Analyst

TL;DR Routine Rule 144 notice: insider plans to sell 100,000 shares valued at $2.33M; prior 25,000-share sale reported.

The filing documents a planned brokered sale of 100,000 common shares via Morgan Stanley Smith Barney with an aggregate market value of $2,331,000 and lists the specific vesting lots by date and amount that comprise the block. A separate transaction shows 25,000 shares sold on 05/16/2025 for $525,500. This is a compliance-focused disclosure under Rule 144; it documents source-of-acquisition (restricted stock vesting) and prior disposals but does not provide operational or financial performance details about the issuer.

Corporate Governance Expert

TL;DR Disclosure indicates vested restricted stock being monetized through a brokered sale; filing follows Rule 144 mechanics.

The notice shows that the shares to be sold were acquired through restricted stock vesting under a registered plan across multiple dates in 2024–2025, and the sale is to be executed through a named broker, indicating adherence to transfer and reporting procedures. The document includes the representation that the seller is not aware of undisclosed material adverse information. The filing itself is procedural and does not signal company financial changes; governance implications depend on whether insider sales continue or accelerate.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	100000	2331000.00	65606760	08/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/01/2024	Restricted stock vesting under a registered plan	Issuer			6566	01/01/2024	Not Applicable
Common	01/01/2024	Restricted stock vesting under a registered plan	Issuer			6020	01/01/2024	Not Applicable
Common	11/10/2024	Restricted stock vesting under a registered plan	Issuer			33681	11/10/2024	Not Applicable
Common	01/01/2025	Restricted stock vesting under a registered plan	Issuer			7872	01/01/2025	Not Applicable
Common	01/01/2025	Restricted stock vesting under a registered plan	Issuer			10204	01/01/2025	Not Applicable
Common	03/01/2025	Restricted stock vesting under a registered plan	Issuer			10581	03/01/2025	Not Applicable
Common	02/26/2025	Restricted stock vesting under a registered plan	Issuer			25076	02/26/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Megan Jane Graves WELLESLEY HOUSE NORTH 90 PITTS BAY ROAD PEMBROKE D0 HM 08	Common	05/16/2025	25000	525500.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Hamilton Insurance (HG) report?

The form reports a proposed sale of 100,000 common shares via Morgan Stanley Smith Barney with an aggregate market value of $2,331,000 and an approximate sale date of 08/12/2025.

How were the 100,000 shares acquired?

The filing states the shares were acquired as restricted stock vesting under a registered plan on multiple dates in 2024–2025, with vesting lots that total 100,000 shares.

Has the insider sold shares recently?

Yes. The filing discloses that Megan Jane Graves sold 25,000 shares on 05/16/2025 for gross proceeds of $525,500.

Who is the broker named in the Form 144?

The broker listed for the proposed sale is Morgan Stanley Smith Barney LLC Executive Financial Services at the address shown in the notice.

How many shares does the issuer have outstanding according to the filing?

The filing lists 65,606,760 shares outstanding for the issuer.

Does the filing state there is undisclosed adverse information?

The signer represents they do not know of any material adverse information about the issuer that has not been publicly disclosed.